Transpire Bio

Executive Summary

Transpire Bio is a San Diego-based private biopharmaceutical company founded in 2021, specializing in advanced inhalation formulation and delivery platforms. The company applies its patented technologies to drugs with known mechanisms of action, aiming to improve therapeutic outcomes for diseases with significant unmet needs. By optimizing delivery and tolerability, Transpire Bio seeks to unlock the full potential of existing therapies, particularly in respiratory and systemic conditions where inhaled administration can offer advantages over oral or injectable routes.

Upcoming Catalysts (preview)

• Q4 2026Phase 1 clinical trial data readout for lead candidate55% success
• Q2 2026Announcement of strategic partnership for development or commercialization40% success
• Q3 2026Series A financing round closing70% success